Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Gastro One
mi
from
Germantown, TN
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Status: Enrolling
Updated:  5/22/2013
Stanford Digestive Health Center
mi
from
Stanford, CA
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Status: Enrolling
Updated: 5/22/2013
Stanford Digestive Health Center
mi
from
Stanford, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Glendale, AZ
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Anaheim, CA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Aurora, CO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
New Haven, CT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Jacksonville, FL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Roswell, GA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Joliet, IL
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Joliet, IL
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Louisville, KY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Bethesda, MD
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Boston, MA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Rochester, MN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Chesterfield, MO
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
New York, NY
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Durham, NC
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Cincinnati, OH
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Weatherford, OK
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Weatherford, OK
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Klamath Falls, OR
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Klamath Falls, OR
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Philadelphia, PA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Knoxville, TN
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Salt Lake City, UT
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Richmond, VA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
Kennewick, WA
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
Kennewick, WA
Click here to add this to my saved trials
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated:  5/23/2013
GSK Investigational Site
mi
from
La Crosse, WI
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
A 52 Week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Status: Enrolling
Updated: 5/23/2013
GSK Investigational Site
mi
from
La Crosse, WI
Click here to add this to my saved trials
Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure
Endoscopic Esophageal Myotomy for the Treatment of Achalasia
Status: Enrolling
Updated:  6/7/2013
Masschusetts General Hospital
mi
from
Boston, MA
Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure
Endoscopic Esophageal Myotomy for the Treatment of Achalasia
Status: Enrolling
Updated: 6/7/2013
Masschusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
The Efficacy of Timolol 0.5% Gel Forming Solution for the Treatment of Ulcerated Hemangiomas
Status: Enrolling
Updated:  6/11/2013
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
The Efficacy of Timolol 0.5% Gel Forming Solution for the Treatment of Ulcerated Hemangiomas
Status: Enrolling
Updated: 6/11/2013
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
A Phase 1, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
Status: Enrolling
Updated:  6/13/2013
Clinical Research Facility
mi
from
Miami, FL
A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
A Phase 1, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
Status: Enrolling
Updated: 6/13/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
A Phase 1, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
Status: Enrolling
Updated:  6/13/2013
Clinical Research Facility
mi
from
Orlando, FL
A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
A Phase 1, Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function
Status: Enrolling
Updated: 6/13/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
A Phase II, Double-blind, Randomized, Placebo-controlled 4-way Crossover Study to Evaluate the Relative Efficacy and Safety of OC Oral Solution (Oxybutynin and Clonidine) for Sialorrhoea in Patients With Parkinson's Disease
Status: Enrolling
Updated:  6/14/2013
QUEST Research Institute
mi
from
Bingham Farms, MI
A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
A Phase II, Double-blind, Randomized, Placebo-controlled 4-way Crossover Study to Evaluate the Relative Efficacy and Safety of OC Oral Solution (Oxybutynin and Clonidine) for Sialorrhoea in Patients With Parkinson's Disease
Status: Enrolling
Updated: 6/14/2013
QUEST Research Institute
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Ventura Clinical Trials
mi
from
Malibu, CA
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Ventura Clinical Trials
mi
from
Malibu, CA
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Indiana University Hospital
mi
from
Indianapolis, IN
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
GI Associates and Endoscopy Center
mi
from
Jackson, MS
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
GI Associates and Endoscopy Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Center for Digestive and Liver Diseases, Inc.
mi
from
Mexico City, MO
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Center for Digestive and Liver Diseases, Inc.
mi
from
Mexico City, MO
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated:  6/14/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
A Multicenter, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase II Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis
Status: Enrolling
Updated: 6/14/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease
A Pharmacokinetic Study of Baricitinib in Subjects With Hepatic Dysfunction
Status: Enrolling
Updated:  6/14/2013
Clinical Research Facility
mi
from
Miami, FL
A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease
A Pharmacokinetic Study of Baricitinib in Subjects With Hepatic Dysfunction
Status: Enrolling
Updated: 6/14/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
Click here to add this to my saved trials